Cover Image

Differential Effects of Polyphenols on Insulin Proteolysis by the Insulin-Degrading Enzyme

The insulin-degrading enzyme (IDE) possesses a strong ability to degrade insulin and Aβ42 that has been linked to the neurodegeneration in Alzheimer's disease (AD). Given this, an attractive IDE-centric strategy for the development of therapeutics for AD is to boost IDE's activity for the...

Full description

Saved in:

Bibliographic Details
Main Authors:	Qiuchen Zheng (Author), Micheal T. Kebede (Author), Bethany Lee (Author), Claire A. Krasinski (Author), Saadman Islam (Author), Liliana A. Wurfl (Author), Merc M. Kemeh (Author), Valerie A. Ivancic (Author), Charles E. Jakobsche (Author), Donald E. Spratt (Author), Noel D. Lazo (Author)
Format:	Book
Published:	MDPI AG, 2021-08-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The insulin-degrading enzyme as a link between insulin and neuropeptides metabolism
by: Dorota Wacławczyk, et al.
Published: (2021)

Non-Invasive and Less Degradative Ways of Insulin Administration
by: Saeideh Allahyari, et al.
Published: (2019)

Gingipain from Porphyromonas gingivalis causes insulin resistance by degrading insulin receptors through direct proteolytic effects
by: Fen Liu, et al.
Published: (2024)

Proteostasis and Proteolysis
Published: (2022)

Proteostasis and Proteolysis
Published: (2022)

Discovery of the first potent proteolysis targeting chimera (PROTAC) degrader of indoleamine 2,3-dioxygenase 1
by: Mingxing Hu, et al.
Published: (2020)

Neuroplasticity and Extracellular Proteolysis
by: Leszek Kaczmarek
Published: (2016)

Disorder-specific effects of polymorphisms at opposing ends of the <it>Insulin Degrading Enzyme </it>gene
by: Bartl Jasmin, et al.
Published: (2011)

Selective degradation of hyperphosphorylated tau by proteolysis-targeting chimeras ameliorates cognitive function in Alzheimer's disease model mice
by: Dongping Yao, et al.
Published: (2024)

Perlecan and the Blood-Brain Barrier: Beneficial Proteolysis?
by: Jill eRoberts, et al.
Published: (2012)

Insulin alleviates degradation of skeletal muscle protein by inhibiting the ubiquitin-proteasome system in septic rats
by: Gao Tao, et al.
Published: (2011)

Concentrated insulins: the new basal insulins
by: Lamos EM, et al.
Published: (2016)

Coventional insulin versus insulin analogs
by: Anil Gomber, et al.
Published: (2019)

Synthesis and discovery of the first potent proteolysis targeting chimaera (PROTAC) degrader of AIMP2-DX2 as a lung cancer drug
by: BoRa Lee, et al.
Published: (2023)

Tyrosine-phosphorylated DNER sensitizes insulin signaling in hepatic gluconeogenesis by inducing proteasomal degradation of TRB3
by: Junfeng Li, et al.
Published: (2024)

CLINICAL AND ECONOMIC BENEFITS OF HUMAN INSULIN ANALOGUESUSE
by: E. E. Arinina, et al.
Published: (2015)

Insulin and Insulin-Sensitizing Drugs in Neurodegeneration: Mitochondria as Therapeutic Targets
by: Paula I. Moreira, et al.
Published: (2009)

Insulin-derived amyloidosis: The insulin ball, amyloidoma
by: Curt Samlaska, MD, et al.
Published: (2020)

Insulin receptor trafficking steers insulin action
by: Simone Hausmann, et al.
Published: (2016)

A polyphenol-rich cranberry extract reverses insulin resistance and hepatic steatosis independently of body weight loss
by: Fernando F. Anhê, et al.
Published: (2017)

Seborrheic keratosis and insulin resistans
by: A. K. Aleksandrova, et al.
Published: (2017)

On Digestive Proteolysis Being the Cartwright Lectures for 1894
by: Chittenden, R. H. (Russell Henry), 1856-1943

Proteolysis-targeting chimeras and their implications in breast cancer
by: Angeles C. Tecalco-Cruz, et al.
Published: (2021)

The clinical advances of proteolysis targeting chimeras in oncology
by: Hao Xie, et al.
Published: (2021)

The Expense of Insulin in Individuals with Insulin-Dependent Diabetes in Fars Province based on Prescribed Prescriptions including Insulin
by: Sanaz Amiri, et al.
Published: (2020)

Neuraminidase 1 activates insulin receptor and reverses insulin resistance in obese mice
by: Anne Fougerat, et al.
Published: (2018)

Early Clinical Detection of Pharmacologic Response in Insulin Action in a Nondiabetic Insulin-Resistant Population
by: Sudha S. Shankar, MD, et al.
Published: (2015)

Icodec insulin - revolution in diabetes type 2 insulin therapy
by: Michał Dobrzyński, et al.
Published: (2022)

Pharmacoeconomic comparison of the second generation insulin analogs and insulins on their base
by: I. N. Dyakov, et al.
Published: (2021)

Insulin Resistance
Published: (2012)

Insulin Overdose
by: Richard Stair
Published: (2008)

History of insulin
by: Celeste C. Quianzon, et al.
Published: (2012)

Insulin degludec
by: Vishakha V Jain, et al.
Published: (2013)

Cost-effectiveness of insulin degludec/insulin aspart versus biphasic insulin aspart in Chinese population with type 2 diabetes
by: Qiong Luo, et al.
Published: (2022)

In celebration of a century with insulin - Update of insulin gene mutations in diabetes
by: Julie Støy, et al.
Published: (2021)

Investigation of factors that cause insulin precipitation and/or amyloid formation in insulin formulations
by: Yui Ohno, et al.
Published: (2019)

DIAGNOSIS OF RENAL HEMODYNAMICS DISORDERS IN CHILDREN AND ADOLESCENTS WITH INSULIN DEPENDENT DIABETES
by: E.A. Azova
Published: (2008)

DIAGNOSIS OF RENAL HEMODYNAMICS DISORDERS IN CHILDREN AND ADOLESCENTS WITH INSULIN DEPENDENT DIABETES
by: E.A. Azova
Published: (2008)

The brain as an insulin-sensitive metabolic organ
by: Joshua L. Milstein, et al.
Published: (2021)

Effects of some anti-diabetic herbal extracts on the insulin-degrading enzyme in human colon cancer Caco-2 cell line
by: Mahtab Norouzi, et al.
Published: (2022)